Status:
UNKNOWN
Treatment of Severe Limb Ischemia With Autologous Bonemarrow Derived Mononuclear Cells
Lead Sponsor:
Odense University Hospital
Conditions:
Ischemia
Eligibility:
All Genders
20-85 years
Phase:
PHASE1
Brief Summary
The aim of the study is to investigate whether implantation of autologous bone marrow derived stem cells in ishemics limbs will improve vascularization
Detailed Description
10 patients with severe lower limb ischemia will be included in this pilote trial. Bonemarrow aspiration will be performed and and the monocuclear cells isolated an injected into the gastrocnemius. ...
Eligibility Criteria
Inclusion
- Ankle blood pressure \< 70 mmgHG
- Either pain at rest and/or ischemic wound
- No possible surgical treatment
Exclusion
- Infection
- Malignant disease
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2007
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00442143
Start Date
January 1 2007
End Date
December 1 2007
Last Update
July 23 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of endocrinology M, Odense University Hospital
Odense, Denmark, 5000